# Simultaneous Transcatheter Aortic Valve Replacement and Endovascular Aortic Aneurysm Repair—The First Case in Serbia

**Authors:** Darko Boljević, Jovana Lakčević, Mihajlo Farkić, Vladimir Mihajlović, Stefan Veljković, Armin Šljivo, Marina Lukić, Milovan Bojić, Aleksandra Nikolić

PMC · DOI: 10.3390/diagnostics15212785 · 2025-11-03

## TL;DR

This paper reports the first case in Serbia of a 75-year-old man undergoing simultaneous heart and aortic procedures, showing it can be done safely with proper planning.

## Contribution

The first documented case in Serbia of simultaneous TAVR and EVAR in a high-risk elderly patient.

## Key findings

- The combined procedure was successfully performed with no major complications during surgery.
- At six-month follow-up, the valve function was optimal and the endoleak was managed conservatively.
- The case highlights the importance of a multidisciplinary team for such complex interventions.

## Abstract

Background and Clinical Significance: Concomitant severe aortic stenosis (AS) and abdominal aortic aneurysm (AAA) in elderly patients presents a significant therapeutic challenge. While transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair (EVAR) have become established minimally invasive treatments for high-risk patients, simultaneous management of both conditions remains rare. Case Presentation: We report the first documented case in Serbia of a simultaneous TAVR and EVAR in a 75-year-old male with severe symptomatic AS and AAA. The patient had a history of hypertension, diabetes mellitus, atrial fibrillation, prior radiofrequency pulmonary vein ablation, and pacemaker implantation. Echocardiography demonstrated severe AS with a transvalvular gradient of 116/61 mmHg, an aortic valve area of 0.6 cm2, and a left ventricular ejection fraction of 30–35%. Coronary angiography revealed 50–60% stenosis of the right coronary artery. Following evaluation by a multidisciplinary Heart and Vascular Team, a combined procedure was performed under general anesthesia via bilateral femoral access. TAVR with a Medtronic Evolut R valve was successfully deployed, followed by EVAR with satisfactory stent graft positioning and angiographic results. The patient’s postoperative course was uneventful, and he was discharged on the ninth day. At six-month follow-up, echocardiography showed optimal valve function, and CT identified a type II endoleak, which was managed conservatively. Conclusions: This case demonstrates the feasibility and safety of simultaneous TAVR and EVAR in a high-risk elderly patient, emphasizing the importance of careful preoperative planning and a coordinated multidisciplinary approach. Further studies are warranted to establish standardized guidelines for the management of patients with coexisting severe AS and AAA.

## Linked entities

- **Diseases:** aortic stenosis (MONDO:0042981), abdominal aortic aneurysm (MONDO:0005350), diabetes mellitus (MONDO:0005015), atrial fibrillation (MONDO:0004981)

## Full-text entities

- **Diseases:** AS (MESH:D001024), hypertension (MESH:D006973), atrial fibrillation (MESH:D001281), stenosis (MESH:D003251), diabetes mellitus (MESH:D003920), AAA (MESH:D017544), type II endoleak (MESH:D057867), Aneurysm (MESH:D000783)
- **Chemicals:** Evolut (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12609993/full.md

---
Source: https://tomesphere.com/paper/PMC12609993